Wild speculation about Oxymetazoline AGN-199201

News, information and research from the world of rosacea.

Wild speculation about Oxymetazoline AGN-199201

Postby David Pascoe » Fri Dec 11, 2015 6:37 am

So we know that Actavis bought Allergan, who were developing the Oxymetazoline based AGN-199201.

If we look at the trademarks that Actavis applied for in 2015 we find the following.


  • pardante
  • lonivista
  • locaring
  • gartovio
  • iscanvia
  • myvivum
  • vilacent
  • limpreo
  • tezzura
  • vessila

I wonder if any of these will be used for oxymetazoline
Get Rosacea News here: https://rosacea-support.org
User avatar
David Pascoe
Moderator Team
 
Posts: 1835
Joined: Sat Jul 07, 2007 3:17 pm
Location: Perth, Western Australia.


Re: Wild speculation about Oxymetazoline AGN-199201

Postby David Pascoe » Thu Apr 14, 2016 8:18 am

I must admit that since I guessed that Galderma would use Soolantra for their Ivermectin based treatment, I thought I'd have a punt at this one too.
Get Rosacea News here: https://rosacea-support.org
User avatar
David Pascoe
Moderator Team
 
Posts: 1835
Joined: Sat Jul 07, 2007 3:17 pm
Location: Perth, Western Australia.

Re: Wild speculation about Oxymetazoline AGN-199201

Postby David Pascoe » Sun May 01, 2016 1:45 pm

My wild speculation was a bit off - I now believe that Allergan will launch their Oxymetazoline based treatment for redness as Azultro.
Get Rosacea News here: https://rosacea-support.org
User avatar
David Pascoe
Moderator Team
 
Posts: 1835
Joined: Sat Jul 07, 2007 3:17 pm
Location: Perth, Western Australia.


Return to Rosacea Research and News